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Abstract: Lower extremity venous ulcers comprise a complex medical and social issue. The conservative and/or surgical 
management of venous ulcers is often inadequate. In addition, the psychosocial aspect of the disease is often overlooked 
and most often undertreated. Common symptoms such as pain, low self-esteem and patient isolation are usually not rec-
ognized and therefore not adequately managed.  
This mini-review summarizes the current data on the management of lower extremity venous ulcers and their impact on 
the quality of life of these patients. 
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INTRODUCTION 
  Chronic venous insufficiency of the lower extremities 
affects approximately 2.5 million people in the USA and has 
an important effect on daily activities and quality of life [1-
3]. Besides pain, swelling, edema, varicosity of the superfi-
cial veins and skin changes, chronic venous insufficiency is 
associated with venous leg ulcers, a condition that requires a 
multidisciplinary and aggressive therapeutic approach [2-
10]. Nearly 500,000 individuals have painful venous ulcers 
[3].  
  Pain is a feature of lower extremity venous ulcers which 
is often overlooked and commonly undertreated [2, 3, 8, 9]. 
Furthermore, psychosocial issues such as anxiety and de-
pression, a low self-esteem and social deprivation are quite 
common in these patients; these issues are often not ade-
quately addressed [2, 3, 8, 9].  
  This mini-review considers the impact of lower extremity 
venous ulcers on quality of life. 
QUALITY OF LIFE IN PATIENTS WITH VASCULAR 
LEG ULCERS 
  A multi-centre, cross-sectional study assessed pain and 
quality of life in patients with chronic vascular leg ulcers by 
use of a questionnaire that incorporated the Short Form (SF)-
12 health survey and a visual analogue scale (VAS) for the 
assessment of pain during the day, night and at dressing 
change [11]. Women experienced more pain and had a worse 
quality of life than men. Venous ulcers had high mean VAS 
values during the day and night (44.4 and 44.9, respectively). 
However, a higher mean value was recorded at dressing 
change, which was similar to the mean VAS value for vascular 
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ulcers (57.5 vs 56.3, respectively). There was a direct corre-
lation between pain and quality of life, which was worse for 
ulcers with a longer duration and larger area. Ulcers of <3 
months' duration had mean VAS values of 38.7, 36.9, 46.8 
compared with 53.8, 53.9, 62.9 for ulcers of >12 months' 
duration. Mean SF-12 values for the physical component of 
the questionnaire also showed that patients whose ulcers had 
a longer duration had a poorer quality of life than patients 
whose ulcers were more recent (35.9 vs 40.9, respectively). 
The conclusion reached was that vascular leg ulcers result in 
a poor quality of life, with a direct correlation with both ul-
cer duration and ulcer area [11].  
  Besides pain, lower extremity venous ulcers also have an 
effect on patient self-esteem and social life. In a study from 
the UK, a questionnaire was distributed to 196 people with 
chronic lower extremity ulcers [12]. This questionnaire 
aimed to determine the impact of odour and excessive exu-
date leading to leakage on patient quality of life. These 
symptoms had an adverse effect on the psychological state, 
leading to feelings of disgust, self-loathing and low self-
esteem. The net result was social isolation and depression 
[12]. 
  In another study, 38 patients with venous leg ulcers com-
pleted a health-related quality of life questionnaire (modified 
Skindex) and were then interviewed by a psychologist using 
a semi-structured guide [13]. Data from the questionnaire 
were used to evaluate the impact of venous leg ulcers on 
patients' lives. Interview transcripts were analysed using 
qualitative methods to identify additional venous leg ulcer-
specific health-related quality of life items. The Skindex 
scores showed that older patients had worse health-related 
quality of life results (p < 0.05), as did those with pain and 
non-healing ulcers. Ulcer duration and size did not correlate 
with quality of life. Based on the results of the interviews, 
pain (80.5%), itching (69.4%), altered appearance (66.7%), 
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appointment with treatment (50%) were identified as the 
psychological effects of venous leg ulcers [13].  
  A recent evaluation study of venous leg ulcer guidelines 
concluded that all lower extremity ulcer practice guidelines 
are evidence-based [14]. There is often a lack of patient per-
spective and use of a uniform method to weigh the evidence. 
In addition, limited attention is given to pain and lifestyle 
advice recommendations. Most of the guidelines fail to con-
sider the issues of dissemination and implementation; fur-
thermore, revisions of the guidelines are often not available. 
The authors recommend that leg ulcer guidelines should in-
corporate a multidisciplinary approach and they underline 
the importance of patient involvement. Finally, recommen-
dations on pain, lifestyle advice, compliance and other qual-
ity-of-life issues should be incorporated in guidelines for leg 
ulcer treatment [14]. 
CONSERVATIVE VS SURGICAL TREATMENT   
OPTIONS FOR VENOUS LEG ULCERS 
  The use of compression stockings, as well as proper 
wound and skin care are the mainstay of conservative treat-
ment of venous leg ulcers [15, 16]. Use of compression 
stockings with 30-40 mmHg of tension results in significant 
improvement in pain, swelling, skin pigmentation, activity 
and patient satisfaction, provided a 70%-80% compliance to 
compression therapy is achieved [15]. With a structured 
regimen of compression therapy more than 9 out of 10 pa-
tients with venous ulcers can achieve complete healing in 
less than half a year (mean time: 5.3 months) [16]. 
  In an 8-week randomised comparison of a 2-layer (Coban 
2 Layer) and a 4-layer (Profore) compression bandage sys-
tem for venous ulcers, the superiority of the former over the 
latter was prominent [17]. The primary endpoint was ban-
dage slippage measured at each dressing change while sec-
ondary endpoints included patient preference, wound healing 
and health-related quality of life. The 2-layer system showed 
less bandage slippage compared with the 4-layer system 
(mean slippage: 2.48 vs 4.17 cm, respectively; p < 0.001). 
The health-related quality of life Physical Symptoms and 
Daily Living scores were also higher for the 2-layer system 
(pooled 2-sample t-test; p < 0.05). Most patients preferred 
the 2-layer over the 4-layer system (72% vs 22%, respec-
tively), with the remaining 6% having no preference. Finally, 
there were no differences in the percent of wounds that 
healed (p = 0.30), in wound area reduction (p = 0.88) or in 
linear healing rate (p = 0.94). These results indicated that, 
while less bandage slippage did not appear to have an impact 
on wound healing, it may have influenced patient preference 
in favour of the 2-layer system and possibly their health-
related quality of life [17].  
  Another study investigated the impact of venous leg ul-
cers and effective compression treatment on quality of life in 
65 patients by use of the SF-36 quality-of-life questionnaire 
[18]. Data analysis included an investigation of the study 
population as whole, differences between patients whose 
ulcers did and did not heal and between gender and age. This 
study showed that there was a significant improvement in the 
SF-36 domains of bodily pain, health transition, mental 
health and social functioning for all 65 patients. Patients 
whose ulcers healed also showed a considerable improve-
ment in the vitality domain. Even patients whose ulcers did 
not heal had improved scores for bodily pain and health tran-
sition. These results demonstrated that good wound man-
agement and effective compression therapy can improve 
quality of life in patients with venous leg ulceration, whether 
or not the patient's leg ulcer healed following treatment [18]. 
  A Cochrane review and meta-analysis was recently pub-
lished including randomised controlled trials either compar-
ing intermittent pneumatic compression (IPC) with control 
(Sham IPC or no IPC) or comparing IPC treatment regimens 
in venous ulcer management [19]. Seven randomised con-
trolled trials (n=367 patients) were identified. Only 1 trial 
reported both allocation concealment and blinded outcome 
assessment. In 1 trial (n=80 patients) more ulcers healed with 
IPC than with dressings (62% vs 28%, respectively; p = 
0.002). Additionally, 4 trials compared IPC with compres-
sion against compression alone. The first of these trials 
(n=45 study participants) found increased ulcer healing with 
IPC plus compression than with compression alone (relative 
risk for healing: 11.4; 95% confidence interval, 1.6-82). The 
remaining 3 trials (n=122 patients) found no evidence of a 
benefit for IPC plus compression compared with compres-
sion alone. One small trial (n=16 patients) found no differ-
ence between IPC (without additional compression) and 
compression bandages alone. Another trial compared differ-
ent ways of delivering IPC (n=104 patients) and found that 
rapid IPC healed more ulcers compared with slow IPC (86% 
vs 61%, respectively; log-rank p = 0.003). The conclusion 
reached was that, compared with no compression, IPC may 
increase healing but whether it increases healing when added 
to treatment with bandages, or if it can be used instead of 
compression bandages is not clear [19]. Further trials are 
required to determine whether IPC increases the healing of 
venous leg ulcers when used in modern practice where com-
pression therapy is widely used. 
  A systematic review showed that while lifestyle is men-
tioned in most leg ulcer guidelines, limited emphasis is paid 
on this subject [20]. This article considered the published 
evidence for the effect of nutrition, leg elevation and exer-
cise on the healing of leg ulcers, as well as the effect of pain-
related interventions. While some evidence was found to 
support a positive effect of leg exercises on the endurance 
and power of the calf muscle and on the haemodynamic 
status of the limb, as well as a positive effect of leg elevation 
during bed rest without compression, no hard evidence was 
found concerning the effect of enriched or altered nutrition 
on wound healing. Nevertheless, there was some evidence of 
nutritional deficits in this patient group. In addition, while 
the use of eutectic mixture of local anaesthetic cream is ef-
fective for reducing pain in wound debridement, pain relief 
in daily life is insufficiently treated. The conclusion reached 
was that, although there is no hard evidence, it can be ex-
pected that interventions such as nutritional monitoring, 
guided exercise and leg elevation will have a substantial im-
pact on wound healing in patients with venous leg ulceration 
[20].  
  The pharmacological management of lower extremity 
venous ulcers due to chronic venous insufficiency is a com-
plex procedure that needs to address several issues. Progres-
sive chronic venous insufficiency may lead to compromised 
skin integrity; it is thus important to keep the area well-
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fections [21]. Use of steroids in cases of stasis dermatitis, as 
well as aggressive wound care and application of appropriate 
antibiotics in cases of venous ulcers and superimposed bacte-
rial infections are additional measures [21]. 
  In addition, several therapeutic approaches have been 
proposed. For example, local application of a hydrogen per-
oxide cream (e.g. Crystacide) in patients with chronic venous 
insufficiency, venous hypertension and skin ulcerations re-
duced the ulcerated areas and improved skin perfusion com-
pared with non-use [22]. Crystacide application improved 
transcutaneous PO2 and decreased PCO2, free radical pro-
duction and laser Doppler flowmetry compared with non-
use. Similar positive results were reported after oral admini-
stration of oxerutins (Venoruton) [23], the endothelium acti-
vator inhibitor and anti-edematous micronised purified fla-
vonoid fraction (Daflon) [24, 25] or Pycnogenol [26]. The 
effects of Pycnogenol in particular appear to extend to other 
vascular disorders as well [27-29]. Nevertheless, a system-
atic review of several oral or topical phlebotonics used (e.g. 
rutosides, calcium dobesilate, disodium flavodate, hidros-
mine, diosmine, centella asiatica, chromocarbe, French mari-
time pine bark extract, grape seed extract and aminaftone) in 
patients with chronic venous insufficiency concluded that 
there is not yet enough evidence to strongly support their 
efficacy in such patients [30]. 
  The effect of several other agents on lower extremity 
venous ulcers has also been evaluated. For example, the use 
of horsechestnut seed extract therapy is an effective, as well 
as cost-effective, alternative treatment for the management 
of venous leg ulcers [31-33]. A similar effect has been advo-
cated for the tumor necrosis factor (TNF)-alpha antibody 
infliximab [34].  
  Besides these pharmacological options, several surgical 
approaches have been described for the management of 
chronic venous leg ulcers. Surgical intervention with regards 
to the deep venous system in the form of venous bypass or 
valve replacement remains disappointing [3, 35]. External 
venous valvuloplasty is an alternative surgical approach 
yielding comparable results [36, 37]. A novel approach in-
cludes the use of stenting for the treatment of chronic venous 
insufficiency, which forms the basis for the development of 
venous leg ulcers [38-40]. The results of both in vitro [38] 
and in vivo [40] studies are promising. Verification of these 
preliminary results in large-scale trials holds implications for 
this treatment.  
  The traditional means of managing the superficial venous 
system when diseased has been to remove it in the forms of 
disconnecting the great or short saphenous veins from the 
deep system at the saphenofemoral or saphenopopliteal junc-
tions, respectively. It is well established that stripping the 
long saphenous vein to below the knee at the same time re-
duces recurrence rates, but there is growing evidence that 
this may also be the case for the short saphenous vein. The 
assumed benefit of these procedures with regards to treating 
chronic venous insufficiency has only recently been verified 
in formal trials [41, 42]; although superficial venous surgery 
plus compression therapy does not appear to improve ulcer 
healing rates when compared with compression therapy 
alone, it is associated with a significantly lower ulcer recur-
rence rate [41-43].  
  The surgical management of incompetent venous perfo-
rator communications between the deep and superficial ve-
nous systems in the leg can be successfully undertaken by a 
subfascial endoscopic method, by laser ablation or foam 
sclerosant exclusion [44-46]. However, there is not enough 
evidence to support that this improves the rate of ulcer heal-
ing or reduces the rate of ulcer recurrence compared with 
external compression [44-46].  
  Debridement of the ulcer wound and addition of a skin 
graft to stimulate healing was proposed as an effective 
treatment of leg ulcers resistant to compression therapy [47, 
48]. Skin grafts are divided into autografts (from the pa-
tient’s own uninjured skin), allograft (bioengineered skin 
grown from donor cells) and xenografts (preserved skin from 
other animals, e.g. pigs). Although preliminary results seem 
promising, there is as yet not enough evidence to determine 
which types of skin grafting should comprise the treatment-
of-choice for leg ulcers resistant to compression therapy [47, 
48]. 
  A study was undertaken to assess the effectiveness of 
skin grafting and the impact on the quality of life of patients 
with chronic venous ulcers [49]. Two groups of patients 
were involved in the study; one was treated by performing 
skin graft surgery, while the other group was treated only by 
conservative means. Patients had to complete a questionnaire 
that was used to evaluate the impact of chronic venous leg 
ulcers on their quality of life. At the beginning of the study 
all patients in both groups suffered from leg pain. At the end 
of the study, the pain had decreased in patients undergoing 
skin graft surgery, while in the group only receiving conser-
vative treatment, the pain practically remained the same. 
Furthermore, at the beginning of the study, the ulcers de-
prived many patients (37-41%) from both groups of sleep for 
most of the night. At the end of the study, ulcers only de-
prived 2.5% of patients in the surgical group for most of the 
night, whereas in the conservative group this percentage was 
reduced to only 20%. The conclusion reached was that skin 
grafting positively influences the quality of life, decreases 
the limitation of function and improves the dysphoric mood. 
The coverage of ulcers by autografts of skin thickness de-
creases leg pain within 6 months compared with conserva-
tive treatment alone (p < 0.05) [49]. 
  An earlier study from the same group compared the func-
tionality of surgical treatment with conservative measures 
for the management of venous leg ulcers [50]. A total of 44 
patients with large trophic leg ulcers (mean size = 254 cm
2) 
were managed for 6 months; 10 patients were treated con-
servatively and 34 patients were treated by skin grafting. All 
of them were interviewed after 3-6 months. Ulcer pain had 
decreased for the patients treated surgically whereas it re-
mained the same for those treated conservatively. Initially, 
all patients (n=44) had sleep disorders because of the ulcers. 
In the group of surgically-treated patients, ulcers did not dis-
turb sleep 3 months following surgery, whereas the problem 
persisted in the group treated conservatively. A considerable 
improvement in the patients’ emotional status was also noted 
[50].  
CONCLUSIONS 
  The appropriate management of venous leg ulcers is 
complex and not fully defined. Venous ulcers have a consid-108    The Open Cardiovascular Medicine Journal, 2008, Volume 2  Koupidis et al. 
erable impact on patients’ well-being and negatively affect 
their quality of life. Besides the establishment of the treat-
ment-of-choice for this disease, it is equally important to 
address the psychosocial issues that usually accompany the 
development of lower extremity venous ulcers. Future stud-
ies should include this important parameter when evaluating 
the efficacy of a proposed treatment strategy. 
REFERENCES 
[1]  Chiesa R, Marone EM, Limoni C, Volonté M, Schaefer E, Petrini 
O. Effect of chronic venous insufficiency on activities of daily liv-
ing and quality of life: correlation of demographic factors with du-
plex ultrasonography findings. Angiology 2007; 58: 440-9. 
[2]  White JV, Ryjewski C. Chronic venous insufficiency. Perspect 
Vasc Surg Endovasc Ther 2005; 17: 319-27. 
[3]  Eberhardt RT, Raffeto JD. Chronic venous insufficiency. Circula-
tion 2005; 111: 2398-409. 
[4]  Kantor J, Margolis D. Management of leg ulcers. Semin Cutan 
Med Surg 2003; 22: 212-21. 
[5]  Bongiovanni CM, Hughes MD, Bomengen RW. Accelerated 
wound healing: multidisciplinary advances in the care of venous 
leg ulcers. Angiology 2006; 57: 139-44. 
[6]  O’Meara S, Al-Kurdi D, Ovington LG. Antibiotics and antiseptics 
for venous leg ulcers. Cochrane Database Syst Rev 2008; 1: 
CD003557. 
[7]  Al-Kurdi D, Bell-Syer SE, Flemming K. Therapeutic ultrasound for 
venous leg ulcers. Cochrane Database Syst Rev 2008; 1: 
CD001180. 
[8]  Barron GS, Jacob SE, Kirsner RS. Dermatologic complications of 
chronic venous disease: medical management and beyond. Ann 
Vasc Surg 2007; 21: 652-62. 
[9]  Herschthal J, Kirsner RS. Current management of venous ulcers: an 
evidence-based review. Surg Technol Int 2008; 17: 77-83. 
[10]  Heinen MM, Persoon A, van de Kerkhof P, Otero M, van Achter-
berg T. Ulcer-related problems and health care needs in patients 
with venous leg ulcerations: a descriptive, cross-sectional study. Int 
J Nurs Stud 2007; 44: 1296-303. 
[11]  Guarnera G, Tinelli G, Abeni D, Di Pietro C, Sampogna F, Tabolli 
S. Pain and quality of life in patients with vascular leg ulcers: an 
Italian multicentre study. J Wound Care 2007; 16: 347-51. 
[12]  Jones JE, Robinson J, Barr W, Carlisle C. Impact of exudates and 
odour from chronic venous leg ulceration. Nurs Stand 2008; 22: 53-
4. 
[13]  Hareendran A, Bradbury A, Budd J, et al. Measuring the impact of 
venous leg ulcers on quality of life. J Wound Care 2005; 14: 53-7. 
[14]  Van Hecke A, Grypdonck M, Defloor T. Guidelines for the man-
agement of venous leg ulcers: a gap analysis. J Eval Clin Pract 
2008; In process citation 
[15]  Motykie GD, Caprini JA, Arcelus JI, Reyna JJ, Overom E, 
Mokhtee D. Evaluation of therapeutic compression stockings in the 
treatment of chronic venous insufficiency. Dermatol Surg 1999; 25: 
116-20. 
[16]  Mayberry JC, Moneta GL, Taylor LM Jr, Porter JM. Fifteen-year 
results of ambulatory compression therapy for chronic venous ul-
cers. Surgery 1991; 109: 575-81. 
[17]  Moffatt CJ, Edwards L, Collier M, et al. A randomised controlled 
8-week crossover clinical evaluation of the 3M coban 2 layer com-
pression system versus profore to evaluate the product performance 
in patients with venous leg ulcers. Int Wound J 2008; 5: 267-79. 
[18]  Charles H. Does leg ulcer treatment improve patients’ quality of 
life? J Wound Care 2004; 13: 209-13. 
[19]  Nelson EA, Mani R, Vowden K. Intermittent pneumatic compres-
sion for treating venous leg ulcers. Cochrane Database Syst Rev 
2008; 12: CD001899. 
[20]  Heinen MM, van Achterberg T, op Reimer WS, van de Kerkhof 
PC, de Laat E. Venous leg ulcer patients: a review of the literature 
on lifestyle and pain-related interventions. J Clin Nurs 2004; 13: 
355-66. 
[21]  Felty CL, Rooke TW. Compression therapy for chronic venous 
insufficiency. Semin Vasc Surg 2005; 18: 36-40. 
[22]  Belcaro G, Cesarone MR, Errichi BM, et al. Improvement of mi-
crocirculation and healing of venous hypertension and ulcers with 
Crystacide: evaluation with a microcirculatory model, including 
free radicals, laser doppler flux, and PO2/PCO2 measurements. 
Angiology 2007; 58: 323-8. 
[23]  Cesarone MR, Belcaro G, Pellegrini L, et al. Venoruton vs Daflon: 
evaluation of effects on quality of life in chronic venous insuffi-
ciency. Angiology 2006; 57: 131-8. 
[24]  Katsenis K. Micronized purified flavonoid fraction (MPFF): a 
review of its pharmacological effects, therapeutic efficacy and 
benefits in the management of chronic venous insufficiency. Curr 
Vasc Pharmacol 2005; 3: 1-9. 
[25]  Bergan JJ. Chronic venous insufficiency and the therapeutic effects 
of Daflon 500 mg. Angiology 2005; 56 (Suppl 1): S21-4. 
[26]  Cesarone MR, Belcaro G, Rohdewald P, et al. Rapid relief of 
signs/symptoms in chronic venous microangiopathy with pycno-
genol: a prospective, controlled study. Angiology 2006; 57: 569-76. 
[27]  Cesarone MR, Belcaro G, Rohdewald P, et al. Improvement of 
diabetic microangiopathy with pycnogenol: A prospective, control-
led study. Angiology 2006; 57: 431-6. 
[28]  Vinciguerra G, Belcaro G, Cesarone MR, et al. Cramps and muscu-
lar pain: prevention with pycnogenol in normal subjects, venous pa-
tients, athletes, claudicants and in diabetic microangiopathy. An-
giology 2006; 57: 331-9. 
[29]  Cesarone MR, Belcaro G, Pellegrini L, et al. HR, 0–(beta–
hydroxyethyl)–rutosides; (Venoruton): rapid relief of 
signs/symptoms in chronic venous insufficiency and microangiopa-
thy: a prospective, controlled study. Angiology 2005; 56: 165-72. 
[30]  Martinez MJ, Bonfill X, Moreno RM, Vargas E, Capellà D. Phle-
botonics for venous insufficiency. Cochrane Database Syst Rev 
2005; 20:CD003229. 
[31]  Leach MJ, Pincombe J, Foster G. Using horsechestnut seed extract 
in the treatment of venous leg ulcers: a cost–benefit analysis. 
Ostomy Wound Manage 2006; 52: 68-70, 72-4, 76-8. 
[32]  Leach MJ, Pincombe J, Foster G. Clinical efficacy of horsechestnut 
seed extract in the treatment of venous ulceration. J Wound Care 
2006; 15: 159-67. 
[33]  Suter A, Bommer S, Rechner J. Treatment of patients with venous 
insufficiency with fresh plant horse chestnut seed extract: a review 
of 5 clinical studies. Adv Ther 2006; 23: 179-90. 
[34]  Streit M, Beleznay Z, Braathen LR. Topical application of the 
tumour necrosis factor–alpha antibody infliximab improves healing 
of chronic wounds. Int Wound J 2006; 3: 171-9. 
[35]  Welch HJ. Surgical options for the treatment of venous ulcers. 
Vasc Endovascular Surg 2004; 38: 195-202. 
[36]  Rosales A, Slagsvold CE, Kroese AJ, Stranden E, Risum Ø, 
Jørgensen JJ. External venous valve plasty (EVVP) in patients with 
primary chronic venous insufficiency (PCVI). Eur J Vasc Endovasc 
Surg 2006; 32: 570-6. 
[37]  Wang SM, Hu ZJ, Li SQ, Huang XL, Ye CS. Effect of external 
valvuloplasty of the deep vein in the treatment of chronic venous 
insufficiency of the lower extremity. J Vasc Surg 2006; 44: 1296-
300. 
[38]  Geselschap JH, van Zuiden JM, Toonder IM, Wittens CH. In vitro 
evaluation of a new autologous valve-stent for deep venous incom-
petence. J Endovasc Ther 2006; 13: 762-9. 
[39]  Mussa FF, Peden EK, Zhou W, Lin PH, Lumsden AB, Bush RL. 
Iliac vein stenting for chronic venous insufficiency. Tex Heart Inst 
J 2007; 34: 60-6. 
[40]  Neglen P, Hollis KC, Raju S. Combined saphenous ablation and 
iliac stent placement for complex severe chronic venous disease. J 
Vasc Surg 2006; 44: 828-33. 
[41]  Gohel MS, Barwell JR, Wakely C, et al. The influence of superfi-
cial venous surgery and compression on incompetent calf perfora-
tors in chronic venous leg ulceration. Eur J Vasc Endovasc Surg 
2005; 29: 78-82. 
[42]  Gohel MS, Barwell JR, Earnshaw JJ, et al. Randomized clinical 
trial of compression plus surgery versus compression alone in 
chronic venous ulceration (ESCHAR study)--haemodynamic and 
anatomical changes. Br J Surg 2005; 92: 291-7. 
[43]  Puggioni A, Kalra M, Gloviczki P. Superficial vein surgery and 
SEPS for chronic venous insufficiency. Semin Vasc Surg 2005; 18: 
41-8. 
[44]  Baron HC, Wayne MG, Santiago C, et al. Treatment of severe 
chronic venous insufficiency using the subfascial endoscopic perfo-
rator vein procedure. Surg Endosc 2005; 19: 126-9. 
[45]  Puggioni A, Kalra M, Gloviczki P. Superficial vein surgery and 
SEPS for chronic venous insufficiency. Semin Vasc Surg 2005; 18: 
41-8. The Impact of Lower Extremity Venous Ulcers due to Chronic Venous  The Open Cardiovascular Medicine Journal, 2008, Volume 2    109 
[46]  Bergan JJ, Pascarella L. Severe chronic venous insufficiency: pri-
mary treatment with sclerofoam. Semin Vasc Surg 2005; 18: 49-56. 
[47]  Jones JE, Nelson EA. Skin grafting for venous leg ulcers. Cochrane 
Database Syst Rev 2007; 2: CD001737. 
[48]  Marston W. Evaluation and treatment of leg ulcers associated with 
chronic venous insufficiency. Clin Plast Surg 2007; 34: 717-30. 
[49]  Jankunas V, Bagdonas R, Samsanavicius D, Rimdeika R. The 
influence of surgical treatment for chronic leg ulcers on the quality 
dynamics of the patient’s life. Acta Chir Belg 2007; 107: 386-96. 
[50]  Janknas V, Rimdeika R, Jasenas M, Samsanavicius D. Changes in 
patient’s quality of life comparing conservative and surgical treat-
ment of venous leg ulcers. Medicina (Kaunas) 2004; 40: 731-9.  
 
 
Received: November 17, 2008  Revised: November 18, 2008  Accepted: November 19, 2008 
 
© Koupidis et al.; Licensee Bentham Open. 
 
This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-
nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. 
 
 